A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
Open Access
- 30 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (44) , 71833-71840
Abstract
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factorsKeywords
This publication has 32 references indexed in Scilit:
- Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate CancerEuropean Urology, 2013
- Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer ProgressionPLOS ONE, 2012
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangementBritish Journal of Cancer, 2009
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of DiagnosisJNCI: Journal of the National Cancer Institute, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Long-term outcome among men with conservatively treated localised prostate cancerBritish Journal of Cancer, 2006
- Tazarotene-Induced Gene 1 (TIG1) Expression in Prostate Carcinomas and Its Relationship to TumorigenicityJNCI: Journal of the National Cancer Institute, 2002
- Protease Activation in Apoptosis Induced by MALExperimental Cell Research, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999